---
title: "Waters (WAT) Gets a Buy from Wolfe Research"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288329494.md"
description: "Wolfe Research analyst Michael Polark maintained a Buy rating on Waters (WAT) with a $425 price target. This contrasts with the current moderate buy consensus and average price target of $383.80. Polark, who covers healthcare stocks including Boston Scientific and Abbott Laboratories, has a 6.4% average return and 50% success rate on recommendations."
datetime: "2026-06-01T20:55:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288329494.md)
  - [en](https://longbridge.com/en/news/288329494.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288329494.md)
---

# Waters (WAT) Gets a Buy from Wolfe Research

In a report released today, Michael Polark from Wolfe Research maintained a Buy rating on Waters, with a price target of $425.00.

### Claim 55% Off TipRanks

-   Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
-   Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter

Polark covers the Healthcare sector, focusing on stocks such as Boston Scientific, Abbott Laboratories, and Agilent. According to TipRanks, Polark has an average return of 6.4% and a 50.00% success rate on recommended stocks.

Currently, the analyst consensus on Waters is a Moderate Buy with an average price target of $383.80.

### Related Stocks

- [WAT.US](https://longbridge.com/en/quote/WAT.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [A.US](https://longbridge.com/en/quote/A.US.md)

## Related News & Research

- [Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics | WAT Stock News](https://longbridge.com/en/news/288269152.md)
- [What Waters (WAT)'s Diagnostics Wins and Q1 Beat Mean For Shareholders](https://longbridge.com/en/news/288954725.md)
- [Waters Corp. Gets FDA Clearance For BD BACTEC FXI Culture System](https://longbridge.com/en/news/288578590.md)
- [Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research | WAT Stock News](https://longbridge.com/en/news/288269164.md)
- [Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics | WAT Stock News](https://longbridge.com/en/news/288572071.md)